Trials / Sponsors / Stephanie B. Seminara, MD
Stephanie B. Seminara, MD
Academic / Other · 12 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Kisspeptin to Quantify GnRH Neuronal Function in Health and Disease Reproductive Disorder, Neurodegeneration, SARS-CoV 2 | Phase 1 | 2026-03-10 |
| Recruiting | Kisspeptin Administration Subcutaneously to Patients With Hypothalamic Amenorrhea Hypothalamic Amenorrhea, Hypogonadotropic Hypogonadism | Phase 2 | 2025-12-09 |
| Completed | Using Visual Arrays to Support Understanding of Genetic Risk Decision Aid | N/A | 2025-07-28 |
| Completed | Opioid Antagonism in Hypogonadotropic Hypogonadism Hypogonadotropic Hypogonadism, Low Testosterone | Phase 1 | 2025-06-18 |
| Terminated | Recall by Genotype: Neuropeptide Stimulation Reproductive Disorder | Phase 1 | 2023-10-20 |
| Completed | Dampening the Reproductive Axis With Continuous Kisspeptin Reproductive Disorder, PCOS, Polycystic Ovary Syndrome | Phase 1 | 2023-10-06 |
| Recruiting | Kisspeptin Administration Subcutaneously to Patients With IHH Hypogonadotropic Hypogonadism | Phase 2 | 2023-02-03 |
| Completed | Kisspeptin Administration Subcutaneously to Patients With Reproductive Disorders Hypothalamic Amenorrhea, Hypogonadotropic Hypogonadism | Phase 1 | 2022-12-16 |
| Completed | Opioid Antagonism in Individuals Ascertained Through the Partners HealthCare Biobank Reproductive Disorders | Phase 1 | 2022-06-03 |
| Active Not Recruiting | The Molecular Basis of Inherited Reproductive Disorders Hypogonadotropic Hypogonadism, Reproductive Disorder, Kallmann Syndrome | — | 2021-01-21 |
| Withdrawn | Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Physiologic Mixed Meal Tolerance Insulin, Glucose, Healthy Volunteers | Phase 1 | 2019-09-01 |
| Completed | Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism Hypogonadotropic Hypogonadism | Phase 2 | 2019-05-03 |